Literature DB >> 17397930

Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration.

Luni Emdad1, Devanand Sarkar, Zao-Zhong Su, Seok-Geun Lee, Dong-Chul Kang, Jeffrey N Bruce, David J Volsky, Paul B Fisher.   

Abstract

Tumor progression and metastasis are complex processes involving intricate interplay among multiple gene products. Astrocyte elevated gene (AEG)-1 was cloned as an human immunodeficiency virus (HIV)-1-inducible and tumor necrosis factor-alpha (TNF-alpha)-inducible transcript in primary human fetal astrocytes (PHFA) by a rapid subtraction hybridization approach. AEG-1 down-regulates the expression of the glutamate transporter EAAT2; thus, it is implicated in glutamate-induced excitotoxic damage to neurons as evident in HIV-associated neurodegeneration. Interestingly, AEG-1 expression is elevated in subsets of breast cancer, glioblastoma multiforme and melanoma cells, and AEG-1 cooperates with Ha-ras to augment the transformed phenotype of normal immortal cells. Moreover, AEG-1 is overexpressed in >95% of human malignant glioma samples when compared with normal human brain. Overexpression of AEG-1 increases and siRNA inhibition of AEG-1 decreases migration and invasion of human glioma cells, respectively. AEG-1 contains a lung-homing domain facilitating breast tumor metastasis to lungs. These findings indicate that AEG-1 might play a pivotal role in the pathogenesis, progression and metastasis of diverse cancers. Our recent observations indicate that AEG-1 exerts its effects by activating the nuclear factor kappa B (NF-kappaB) pathway and AEG-1 is a downstream target of Ha-ras and plays an important role in Ha-ras-mediated tumorigenesis. These provocative findings are intensifying interest in AEG-1 as a crucial regulator of tumor progression and metastasis and as a potential mediator of neurodegeneration. In this review, we discuss the cloning, structure and function(s) of AEG-1 and provide recent insights into the diverse actions and intriguing properties of this molecule.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17397930      PMCID: PMC2039930          DOI: 10.1016/j.pharmthera.2007.01.010

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  152 in total

1.  Identification of functional domains of the human glutamate transporters EAAT1 and EAAT2.

Authors:  A D Mitrovic; S G Amara; G A Johnston; R J Vandenberg
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

2.  Reciprocal subtraction differential RNA display: an efficient and rapid procedure for isolating differentially expressed gene sequences.

Authors:  D C Kang; R LaFrance; Z Z Su; P B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

3.  Abnormal EAAT2 splicing in amyotrophic lateral sclerosis.

Authors:  D A Collier
Journal:  Mol Psychiatry       Date:  1998-07       Impact factor: 15.992

4.  Effects of feline immunodeficiency virus on astrocyte glutamate uptake: implications for lentivirus-induced central nervous system diseases.

Authors:  N Yu; J N Billaud; T R Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

5.  Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.

Authors:  M W Mayo; C Y Wang; P C Cogswell; K S Rogers-Graham; S W Lowe; C J Der; A S Baldwin
Journal:  Science       Date:  1997-12-05       Impact factor: 47.728

6.  Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons.

Authors:  B D Schlag; J R Vondrasek; M Munir; A Kalandadze; O A Zelenaia; J D Rothstein; M B Robinson
Journal:  Mol Pharmacol       Date:  1998-03       Impact factor: 4.436

7.  Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

Authors:  R C Bargou; F Emmerich; D Krappmann; K Bommert; M Y Mapara; W Arnold; H D Royer; E Grinstein; A Greiner; C Scheidereit; B Dörken
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

8.  Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients.

Authors:  B Sporer; R Paul; U Koedel; R Grimm; M Wick; F D Goebel; H W Pfister
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

9.  The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain.

Authors:  K P Lehre; N C Danbolt
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

10.  The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.

Authors:  W Wang; J L Abbruzzese; D B Evans; L Larry; K R Cleary; P J Chiao
Journal:  Clin Cancer Res       Date:  1999-01       Impact factor: 12.531

View more
  73 in total

Review 1.  Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

Authors:  K Grovit-Ferbas; M E Harris-White
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  Depletion of astrocyte elevated gene-1 suppresses tumorigenesis through inhibition of Akt activity in bladder cancer cells.

Authors:  Lianhua Zhang; Guoliang Yang; Haige Chen; Yiran Huang; Wei Xue; Juanjie Bo
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 3.  Antiretroviral treatment interruptions and risk of non-opportunistic diseases.

Authors:  Kenneth A Lichtenstein
Journal:  Curr HIV/AIDS Rep       Date:  2009-05       Impact factor: 5.071

Review 4.  Molecularly targeted therapies for malignant gliomas.

Authors:  Andreas A Argyriou; Haralabos P Kalofonos
Journal:  Mol Med       Date:  2009 Mar-Apr       Impact factor: 6.354

5.  Prognostic significance of AEG-1 expression in colorectal carcinoma.

Authors:  Hongtao Song; Cong Li; Rui Li; Jingshu Geng
Journal:  Int J Colorectal Dis       Date:  2010-07-13       Impact factor: 2.571

6.  Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.

Authors:  Ilona N Holcomb; Janet M Young; Ilsa M Coleman; Keyan Salari; Douglas I Grove; Li Hsu; Lawrence D True; Martine P Roudier; Colm M Morrissey; Celestia S Higano; Peter S Nelson; Robert L Vessella; Barbara J Trask
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

Review 7.  Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes.

Authors:  Devanand Sarkar; Luni Emdad; Seok-Geun Lee; Byoung Kwon Yoo; Zao-Zhong Su; Paul B Fisher
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

8.  Serum anti-AEG-1 auto-antibody is a potential novel biomarker for malignant tumors.

Authors:  Xi Chen; Ke Dong; Min Long; Fang Lin; Xi Wang; Junxia Wei; Jihong Ren; Huizhong Zhang
Journal:  Oncol Lett       Date:  2012-05-25       Impact factor: 2.967

9.  Astrocyte elevated gene-1: a novel target for human glioma therapy.

Authors:  Luni Emdad; Devanand Sarkar; Seok-Geun Lee; Zhao Zhong Su; Byoung Kwon Yoo; Rupesh Dash; Adly Yacoub; Christine E Fuller; Khalid Shah; Paul Dent; Jeffrey N Bruce; Paul B Fisher
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

10.  Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis.

Authors:  Luni Emdad; Seok-Geun Lee; Zhao Zhong Su; Hyun Yong Jeon; Habib Boukerche; Devanand Sarkar; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.